Karin Jooss serves as Executive at FATE THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Karin Jooss has executed 9 insider transactions totaling $44.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on May 16, 2024 involved selling 13,749 shares valued at $10.3K.
Karin Jooss currently holds 683,526 shares of FATE THERAPEUTICS INC (FATE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karin Jooss has been a net seller of FATE stock. They have purchased $0 and sold $44.2K worth of shares.
Karin Jooss's most recent insider trade was on May 16, 2024, when they sold 13,749 shares at $0.75 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 1, 2024 | GRTS | $0 | Award | 40,000 | $N/A | Discretionary |
| Feb 2, 2023 | GRTS | $0 | Award | 252,763 | $N/A | Discretionary |
| Jun 9, 2022 | FATE | $0 | Award | 8,650 | $N/A | Discretionary |
| Jun 3, 2022 | FATE | $33.8K | Sale | 1,483 | $22.82 | Discretionary |
| Jan 31, 2022 | GRTS | $0 | Award | 27,600 | $N/A | Discretionary |
| Jun 2, 2021 | FATE | $0 | Award | 2,681 | $N/A | Discretionary |
| Jan 7, 2021 | GRTS | $0 | Award | 27,900 | $N/A | Discretionary |